Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Concurrent Fluorescence and Sonographically Guided Eradication of High-grade Gliomas and Metastases

NCT: NCT05474573 · RECRUITING

NCT IDNCT05474573
StatusRECRUITING
Start Date2023-11-01
Completion2027-08-31
SponsorSklifosovsky Institute of Emergency Care (OTHER_GOV)
First posted
Last updated

Brief Summary

The objective of the study is to determine whether the combined use of intraoperative fluorescence with 5-aminolevulinic acid (5-ALA) and sonography can achieve a higher rate of gross total resection in hemispheric high-grade gliomas and brain metastases compared to intraoperative fluorescence with 5-ALA alone.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑